The relationship of serotonin to depression in Parkinson's disease

Movement Disorders

Volumn 3, Issue 3, 1988, Pages 237-244

  Mayeux, Richard ^a   Stern, Yaakov ^a   Sano, Mary ^a   Williams, Janet B W ^a   Cote, Lucien J ^a  

^a Columbia University ^*  (United States)

Author keywords

5 Hydroxytryptophan; Parkinson's disease; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; SEROTONIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL TRIAL; DEMENTIA; DEPRESSION; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PARKINSON DISEASE; PHYSIOLOGY;

5-HYDROXYTRYPTOPHAN; AGED; CLINICAL TRIALS; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; HUMAN; HYDROXYINDOLEACETIC ACID; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; PARKINSON DISEASE; SEROTONIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024197139     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870030308     Document Type: Article

References (23)

1. Depression in Parkinson's disease: a quantitative and qualitative analysis
2. Altered serotonin metabolism in depressed patients with Parkinson's disease
3. Clinical and biochemical features of depression in Parkinson's disease
4. Depression, intellectual impairment, and Parkinson's disease
5. Depression and dementia in Parkinson's disease
6. Depression
7. Central serotonin metabolism and frequency of depression
8. Validity of diagnostic interview schedule, version II: DSM III diagnoses
9. Bradyphrenia in Parkinson's disease: clinical features and biochemistry
10. A rating scale for depression
11. Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapy
12. Projection technique for evaluatiing surgery in parkinson's disease
13. Aminergic systems in Alzheimer's disease and Parkinson's disease
14. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer‐type dementia
15. Homovanillic acid and 5‐hydroxiyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type
16. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides
17. SF 5‐hydroxyindolacetic acid levels in suicide schizophrenic patients
18. Parkinson's disease: modification by L‐5‐hydroxytryptophan
19. L‐5‐hydroxytryptophan (L‐5‐HTP) Therapie des morbus Parkinson
20. Serotonin precursors in the treatment of depression
21. Epidemiology of affective disorders
22. Depression in the medically ill: an overview